Tamsulosin HCL 0.4 MG capsule 1000S
Ended Awarded
- Contract number
- SPE2DB25FCZWP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,848
Award facts
- Contract value 100% obligated
- $3,848.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Tamsulosin HCl 0.4 mg capsules in a quantity of 1,000 units, with a ceiling value of $3,848.04. The contract utilizes firm fixed price pricing and is scheduled for completion by August 26, 2025, with performance at the company's Conshohocken, Pennsylvania facility. This delivery order represents a non-set-aside competitive award and operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company supplies an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The parent IDC vehicle enables flexible procurement of pharmaceutical support for customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional award recipients.
Quick answers
Who was awarded contract SPE2DB25FCZWP?
SPE2DB25FCZWP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FCZWP worth?
The government has obligated $3,848 on SPE2DB25FCZWP.
Is contract SPE2DB25FCZWP an order under another contract?
Yes. SPE2DB25FCZWP is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCZWP competed?
The extent of competition for SPE2DB25FCZWP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award